$58.0M
The Series A round was led by Ahren, OMX Ventures, and Paladin Capital Group to develop biomanufacturing platforms.
Constructive Bio rewrites genomes to turn living cells into sustainable biofactories.
Constructive Bio is a synthetic genomics startup that rewrites genomes to build novel biomolecules and sustainable materials. The company originated as a spinout from the University of Cambridge.
Jason Chin
CSO
The Series A round was led by Ahren, OMX Ventures, and Paladin Capital Group to develop biomanufacturing platforms.
The seed round was led by Ahren to commercialise research from the Medical Research Council.